CPD Portal
Skin can show first signs of diabetes
Certain skin conditions commonly seen in dermatology practice, can often be the first signs that a patient has diabetes, said Dr Rakesh Newaj, dermatologist in private practice in Gauteng.
Cardiovascular risk reduction in diabetes mellitus
Globally significant increase in the prevalence of diabetes has been documented and this increase is expected to impact in a major way on health costs, economic costs and quality of life. Diabetes is a complex disease which leads to a multifactorial treatment strategy.
Immune cell linked to type 1 diabetes
A research team from Johns Hopkins Medicine has been the first to document the existence of the long searched-for ‘X cell,’ a ‘rogue hybrid’ immune system cell that may play a key role in the development of type 1 diabetes.
Insulin pens: what do patients prefer?
The use of pens as the preferred means of insulin delivery has become standard over the course of the last decade. Given the importance of adherence to therapy in diabetes management, physicians must keep a patient’s preference in mind.
Lies, damn lies and statistics
Epidemiological studies have long suggested a correlation between hyperglycaemia and higher rates of cardiovascular disease (CVD). Meta-analysis of these studies shows that a 1% increase in Hba1c increases CVD risk by 18%.
Gla-300 Vs IDeg-100: What the first RCT says
MEDICAL CHRONICLE OCTOBER CPD 3 of 4: The BRIGHT study results reflect positively on these second-generation longer-acting basal insulin analogues, both of which reduced HbA1c, glucose profiles and fasting SMPG.
How to combat statin-associated muscle symptoms
MEDICAL CHRONICLE OCTOBER CPD 4 of 4: Despite some potentially severe side effects, statins are possibly the most effective drugs for the prevention and treatment of hypercholesterolemia and coronary heart disease.
Vitamin B deficiency in patients with diabetes
SPECIALIST FORUM AUGUST CPD 1 of 4: Vitamins are actively involved in many metabolic processes of the nervous system. Their deficit may cause severe and, sometimes, irreversible consequences for diabetic patients.
New insulin reduces nocturnal hypoglycaemia
Sanofi is the first company in South African medical history to introduce a newly launched product available at the cost of a clone.
That sugar high
In January 2018 the American Diabetes Association (ADA) updated their Standards of Medical Care for the treatment of type 1 diabetes and diabetes mellitus type 2 (DMT2).
Safety, efficacy of Biosimilar human insulins
Diabetes mellitus (diabetes) affects people worldwide and poses major public health and socio-economic challenges. The disorder was previously thought to be rare or undocumented in rural Africa, but over the past few decades it has emerged as an important non-communicable disease (NCD) in sub-Saharan Africa (SSA).
Achieving glycaemic control
Diabetes is South Africa’s second biggest killer but there is a critical lack of consensus among experts and policymakers about how this growing epidemic should be tackled.
A new era in the management of type 2 Diabetes
Various studies have thrust the sodium glucose cotransporter 2 (SGLT2) inhibitors (‘gliflozin’) into the forefront of T2DM guidelines.
Managing a monster
Diabetes is a life-long disease that affects the way the body handles glucose, a sugar in the blood. Most people with the condition have type 2. Type 2 diabetes has been increasing substantially over the last 20 years.
SMART diabetes care
Diabetes has become a leading cause of death worldwide. Although there is no cure for diabetes, blood glucose monitoring combined with appropriate medication can enhance treatment efficiency, alleviate the symptoms, as well as diminish complications.
